Invenomic Capital Management Aggressively Expands Stake in LiveRamp Holdings
Key Takeaways
- Invenomic Capital Management LP has increased its position in LiveRamp Holdings by 61.4%, signaling strong institutional confidence in the data connectivity platform.
- The move, disclosed in a recent SEC filing, brings Invenomic's total stake to nearly 470,000 shares.
Mentioned
Key Intelligence
Key Facts
- 1Invenomic Capital Management LP increased its stake in LiveRamp Holdings by 61.4%.
- 2The fund acquired an additional 178,799 shares during the reporting period.
- 3Total shares held by Invenomic now stand at 469,766.
- 4The transaction was disclosed via a Form 13F filing with the Securities & Exchange Commission.
- 5LiveRamp operates as a leading data connectivity platform on the New York Stock Exchange under the ticker RAMP.
LiveRamp Holdings, Inc.
Company- Ticker
- RAMP
- Exchange
- NYSE
- Focus
- Identity Resolution
A leading data connectivity platform that enables companies and their partners to better connect, control, and activate data to transform customer experiences.
Analysis
The recent disclosure that Invenomic Capital Management LP has bolstered its position in LiveRamp Holdings, Inc. (NYSE: RAMP) by 61.4% represents a significant institutional endorsement of the company's trajectory within the data connectivity and identity resolution market. According to the most recent Form 13F filing with the Securities & Exchange Commission, Invenomic acquired an additional 178,799 shares during the third quarter, bringing its total holdings to 469,766 shares. This aggressive accumulation by a sophisticated institutional player suggests a belief that LiveRamp is undervalued relative to its pivotal role in the evolving digital advertising ecosystem.
LiveRamp occupies a unique position as a neutral infrastructure provider for data collaboration. As the industry moves away from third-party cookies—driven by Google’s ongoing Privacy Sandbox initiatives and Apple’s App Tracking Transparency (ATT)—the demand for first-party data solutions has surged. LiveRamp’s Authenticated Traffic Solution (ATS) has emerged as a leading alternative, allowing publishers and advertisers to connect data without relying on invasive tracking. Invenomic’s decision to increase its stake by such a substantial margin likely reflects a bet on the continued adoption of ATS and the company's broader 'Data Clean Room' capabilities.
According to the most recent Form 13F filing with the Securities & Exchange Commission, Invenomic acquired an additional 178,799 shares during the third quarter, bringing its total holdings to 469,766 shares.
The competitive landscape for identity resolution is intensifying, with major players like Snowflake and TransUnion’s TruAudience competing for market share. However, LiveRamp’s strategic acquisition of Habu, a leader in data clean room technology, has significantly strengthened its moat. By integrating Habu’s technology, LiveRamp has simplified the way companies collaborate on data across different clouds and walled gardens, addressing a major pain point for enterprise clients. This technological edge is a key factor that institutional investors like Invenomic weigh when committing capital to mid-cap technology firms.
From a market sentiment perspective, institutional accumulation often serves as a leading indicator for retail and smaller institutional investors. When a fund increases a position by more than 60%, it typically indicates a high-conviction play rather than a mere portfolio rebalancing. This move comes at a time when LiveRamp has been focusing on improving its margins and driving subscription-based recurring revenue. The shift toward a more predictable revenue model is highly attractive to asset managers looking for stability in the volatile software-as-a-service (SaaS) sector.
What to Watch
However, the path forward is not without regulatory hurdles. The data privacy landscape remains in flux, with the SEC and various international bodies continuously updating guidelines on how consumer data can be handled and reported. LiveRamp’s business model is inherently tied to these regulations. Investors will be watching closely to see if the company can maintain its growth trajectory while navigating increasingly stringent global privacy laws. The fact that Invenomic is expanding its stake suggests they view LiveRamp’s compliance-first architecture as a competitive advantage rather than a liability.
Looking ahead, market participants should monitor upcoming quarterly earnings reports for signs of accelerated ATS adoption and the successful cross-selling of Habu’s clean room solutions. If LiveRamp can demonstrate that its platform is becoming the industry standard for post-cookie identity, the institutional momentum seen from Invenomic may be just the beginning of a broader re-rating of the stock. For now, this 13F filing provides a clear signal that professional money managers see a compelling risk-reward profile in the data connectivity leader.
From the Network
Invenomic Capital Management Boosts LiveRamp Stake by 61% Amid AdTech Shift
Invenomic Capital Management LP significantly increased its position in LiveRamp Holdings, Inc. (NYSE: RAMP), acquiring an additional 178,799 shares during the third quarter. This 61.4% boost brings t
SaaSInvenomic Capital Boosts LiveRamp Stake by 61% Amid Data Privacy Shift
Invenomic Capital Management LP has significantly expanded its position in LiveRamp Holdings, Inc. (NYSE: RAMP), increasing its stake by 61.4% to 469,766 shares. This institutional move underscores gr